Verve Therapeutics, Inc. (VERV) has a market capitalization of $994.04M and trades at $11.13. The 52-week range is 2.865-11.405.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.7, Earnings Per Share (EPS) of $-2.36, annual revenue of $32.33M.
The stock has a beta of 2.24, operates in the Healthcare sector.
